CLEC7A and neoplasm: Studies have shown that Dectin-1-activated DCs can induce the anti-tumour effects of Th9 cells and Dectin-1 is essential for natural killer (NK) cell-mediated killing of tumour cells expressing N-glycans [17, 18].